NO964427D0 - In vivo genekspresjonssystem - Google Patents
In vivo genekspresjonssystemInfo
- Publication number
- NO964427D0 NO964427D0 NO964427A NO964427A NO964427D0 NO 964427 D0 NO964427 D0 NO 964427D0 NO 964427 A NO964427 A NO 964427A NO 964427 A NO964427 A NO 964427A NO 964427 D0 NO964427 D0 NO 964427D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- target
- altering
- inhibiting
- sec
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 4
- 238000001727 in vivo Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 abstract 1
- 102000053642 Catalytic RNA Human genes 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108091092562 ribozyme Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM5169A AUPM516994A0 (en) | 1994-04-20 | 1994-04-20 | An in vivo gene expression system |
| PCT/AU1995/000235 WO1995029254A1 (en) | 1994-04-20 | 1995-04-20 | An in vivo gene expression system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO964427D0 true NO964427D0 (no) | 1996-10-18 |
Family
ID=3779748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO964427A NO964427D0 (no) | 1994-04-20 | 1996-10-18 | In vivo genekspresjonssystem |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5932435A (no) |
| EP (1) | EP0756634B1 (no) |
| JP (1) | JPH09511911A (no) |
| AT (1) | ATE222959T1 (no) |
| AU (1) | AUPM516994A0 (no) |
| CA (1) | CA2185550A1 (no) |
| DE (1) | DE69527951T2 (no) |
| FI (1) | FI964172A0 (no) |
| IL (1) | IL113430A (no) |
| NO (1) | NO964427D0 (no) |
| WO (1) | WO1995029254A1 (no) |
| ZA (1) | ZA953208B (no) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0862651A2 (en) * | 1995-10-16 | 1998-09-09 | Chiron Corporation | Method of screening for factors that modulate gene expression |
| US5985214A (en) * | 1997-05-16 | 1999-11-16 | Aurora Biosciences Corporation | Systems and methods for rapidly identifying useful chemicals in liquid samples |
| CA2277414A1 (en) | 1997-11-07 | 1999-05-20 | Georges Natsoulis | Surrogate genetics target characterization method |
| AU1009499A (en) * | 1999-01-08 | 2000-11-16 | Johnson & Johnson Research Pty. Limited | Eukaryotic cell-based system for identifying gene modulators |
| US6720139B1 (en) | 1999-01-27 | 2004-04-13 | Elitra Pharmaceuticals, Inc. | Genes identified as required for proliferation in Escherichia coli |
| GB9912965D0 (en) * | 1999-06-03 | 1999-08-04 | Oxford Biomedica Ltd | In vivo selection method |
| CA2374745A1 (en) * | 1999-08-09 | 2001-02-15 | Incyte Genomics, Inc. | Proteases and protease inhibitors |
| JP2003510035A (ja) * | 1999-09-10 | 2003-03-18 | インサイト・ゲノミックス・インコーポレイテッド | アポトーシスタンパク質 |
| JP2003523756A (ja) * | 2000-02-24 | 2003-08-12 | フィロス インク． | 触媒蛋白質の生成のための改良された方法 |
| WO2001066742A2 (en) * | 2000-03-03 | 2001-09-13 | Incyte Genomics, Inc. | G-protein coupled receptors |
| ATE432350T1 (de) | 2000-06-16 | 2009-06-15 | Incyte Corp | G-protein gekoppelte rezeptoren |
| US7608704B2 (en) | 2000-11-08 | 2009-10-27 | Incyte Corporation | Secreted proteins |
| NZ534396A (en) * | 2002-02-01 | 2006-11-30 | Univ Mcgill | Oligonucleotides comprising alternating segments of sugar-modified nucleosides and 2'-deoxynucleosides and uses thereof |
| WO2003070902A2 (en) * | 2002-02-20 | 2003-08-28 | Incyte Corporation | Receptors and membrane-associated proteins |
| DE10210284A1 (de) * | 2002-03-08 | 2003-10-02 | Medigene Ag | Verfahren zum Identifizieren von spezifischen RNA-Inhibitoren |
| AU2003261366A1 (en) * | 2002-08-05 | 2004-02-23 | The Wistar Institute | Methods for regulating brca1-brca2-containing complex activity |
| US20070276126A1 (en) * | 2002-08-13 | 2007-11-29 | Incyte Corporation | Cell adhesion and extracellular matrix proteins |
| EP2163614B1 (en) | 2002-08-21 | 2016-10-12 | Revivicor, Inc. | Porcine animals lacking any expression of functional alpha 1, 3, galactosyltransferase |
| US20070219353A1 (en) * | 2002-09-03 | 2007-09-20 | Incyte Corporation | Immune Response Associated Proteins |
| AU2003279829A1 (en) * | 2002-10-04 | 2004-05-04 | Incyte Corp | Protein modification and maintenance molecules |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| US20050164275A1 (en) * | 2002-10-18 | 2005-07-28 | Incyte Corporation | Phosphodiesterases |
| WO2004044166A2 (en) * | 2002-11-12 | 2004-05-27 | Incyte Corporation | Carbohydrate-associated proteins |
| US20070065820A1 (en) * | 2002-11-13 | 2007-03-22 | Xin Jiang | Lipid-associated molecules |
| US20070009516A1 (en) * | 2002-11-26 | 2007-01-11 | Tran Uyen K | Immune response-associated proteins |
| WO2004092407A1 (en) * | 2003-04-17 | 2004-10-28 | Genesis Group Inc. | Pygopus in diagnosis and treatment of cancer |
| US7829682B1 (en) | 2003-04-30 | 2010-11-09 | Incyte Corporation | Human β-adrenergic receptor kinase nucleic acid molecule |
| CN100581621C (zh) * | 2003-05-16 | 2010-01-20 | 拉瓦勒大学 | Cns氯化物调节及其用途 |
| AU2005244036A1 (en) * | 2004-05-14 | 2005-11-24 | Universite De Laval | Phospholipase C gamma modulation and uses thereof for management of pain and nociception |
| WO2005121339A1 (en) * | 2004-06-09 | 2005-12-22 | Mcgill University | Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| EP1774017B1 (en) | 2004-07-26 | 2013-05-15 | Pfenex Inc. | Process for improved protein expression by strain engineering |
| NZ565711A (en) | 2005-08-09 | 2011-10-28 | Revivicor Inc | Transgenic ungulates expressing a porcine CTLA4 peptide fused to an immunoglobulin |
| US9394571B2 (en) | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| GB0806803D0 (en) * | 2008-04-15 | 2008-05-14 | Scottish Biomedical Ltd | Reverse reporter assay |
| US9822367B2 (en) | 2013-02-21 | 2017-11-21 | Rsem, Limited Partnership | Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability |
| ES2865488T3 (es) | 2014-09-05 | 2021-10-15 | Rsem Lp | Composiciones y métodos para el tratamiento y la prevención de la inflamación |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3618638A1 (de) * | 1986-06-03 | 1987-12-10 | Behringwerke Ag | Verfahren zur sekretion von proteinen aus hefen |
| WO1991016456A1 (en) * | 1990-04-19 | 1991-10-31 | The General Hospital Corporation | Screening assays for compounds which inhibit the binding of c-myc to dna |
| WO1992012635A1 (en) * | 1991-01-18 | 1992-08-06 | Oncogene Science, Inc. | Methods of transcriptionally modulating gene expression of viral genes and other genes |
| JPH07502891A (ja) * | 1991-10-25 | 1995-03-30 | ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ | 菌類の二形性遺伝子 |
| IT1255697B (it) * | 1992-09-29 | 1995-11-10 | Enichem Spa | Metodo per l'espressione nel lievito schizosaccharomyces pombe di recettori del sistema nervoso umano |
| CA2157774A1 (en) * | 1993-04-07 | 1994-10-13 | Christopher John Marshall | Methods for screening of substances for therapeutic activity and yeast for use therein |
| US5443962A (en) * | 1993-06-04 | 1995-08-22 | Mitotix, Inc. | Methods of identifying inhibitors of cdc25 phosphatase |
-
1994
- 1994-04-20 AU AUPM5169A patent/AUPM516994A0/en not_active Abandoned
-
1995
- 1995-04-20 US US08/727,449 patent/US5932435A/en not_active Expired - Fee Related
- 1995-04-20 CA CA002185550A patent/CA2185550A1/en not_active Abandoned
- 1995-04-20 JP JP7527227A patent/JPH09511911A/ja not_active Ceased
- 1995-04-20 WO PCT/AU1995/000235 patent/WO1995029254A1/en active IP Right Grant
- 1995-04-20 ZA ZA953208A patent/ZA953208B/xx unknown
- 1995-04-20 AT AT95916501T patent/ATE222959T1/de not_active IP Right Cessation
- 1995-04-20 DE DE69527951T patent/DE69527951T2/de not_active Expired - Fee Related
- 1995-04-20 IL IL11343095A patent/IL113430A/xx not_active IP Right Cessation
- 1995-04-20 EP EP95916501A patent/EP0756634B1/en not_active Expired - Lifetime
-
1996
- 1996-10-17 FI FI964172A patent/FI964172A0/fi not_active Application Discontinuation
- 1996-10-18 NO NO964427A patent/NO964427D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI964172A (fi) | 1996-10-17 |
| EP0756634B1 (en) | 2002-08-28 |
| DE69527951D1 (de) | 2002-10-02 |
| JPH09511911A (ja) | 1997-12-02 |
| ZA953208B (en) | 1996-01-03 |
| CA2185550A1 (en) | 1995-11-02 |
| AUPM516994A0 (en) | 1994-05-12 |
| IL113430A (en) | 1999-07-14 |
| FI964172A0 (fi) | 1996-10-17 |
| ATE222959T1 (de) | 2002-09-15 |
| EP0756634A4 (en) | 1999-09-01 |
| IL113430A0 (en) | 1995-07-31 |
| EP0756634A1 (en) | 1997-02-05 |
| WO1995029254A1 (en) | 1995-11-02 |
| DE69527951T2 (de) | 2003-04-24 |
| US5932435A (en) | 1999-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI964172A (fi) | Geenin ilmentymisjärjestelmä in vivo | |
| Shi et al. | RNA aptamers as effective protein antagonists in a multicellular organism | |
| Adelman et al. | Herpes simplex virus DNA packaging sequences adopt novel structures that are specifically recognized by a component of the cleavage and packaging machinery | |
| CN107922949A (zh) | 用于通过同源重组的基于crispr/cas的基因组编辑的化合物和方法 | |
| EP0643720A4 (en) | Binding competent oligomers containing 2', 5' linkages. | |
| WO2001045638A3 (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
| Takahama et al. | Loop lengths of G-quadruplex structures affect the G-quadruplex DNA binding selectivity of the RGG motif in Ewing’s sarcoma | |
| DE69834267D1 (de) | Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen | |
| EP0939621A4 (en) | INHIBITION OF BCL-2 PROTEIN EXPRESSION BY LIPOSOMAL ANTISENSE OLIGODE OXYNUCLEOTIDE | |
| ATE315087T1 (de) | Neuartige auf p53 ansprechende gene | |
| Tanaka et al. | Origin of the cloverleaf shape of transfer RNA-the double-hairpin model: implication for the role of tRNA intron and the long extra loop | |
| ATE242318T1 (de) | Rhamnogalacturonan acetylesterase (rgae) von aspergillus aculeatus | |
| Radakovic et al. | Nonenzymatic assembly of active chimeric ribozymes from aminoacylated RNA oligonucleotides | |
| DE69332951D1 (de) | Gensequenzen kodierend für enzyme des flavonoid stoffwechselweges mit einer flavonoid 3'-hydroxylase aktivität une ihre anwendungen | |
| EP1100815A4 (en) | PROTEASE TYPE II CLEAVABLE PEPTIDE | |
| BG104883A (en) | Human bmp-7 promoter and method for exploring bone-related substance by using the same | |
| DE69618574D1 (de) | Vom desmingen abstammende amplifizierungssequenzen, vektoren, die diese enthalten und anwendungen derselben zur herstellung von proteinen | |
| HUP9802681A1 (hu) | Onkogénnel vagy vírussal szabályozott expressziós rendszerek | |
| FR2744455B1 (fr) | Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications | |
| ATE221124T1 (de) | Kombinationsvektoren zum austragen von genmaterial | |
| MX9605278A (es) | Procedimiento para la inactivacion de virus en proteinas. | |
| Benoit et al. | Chimeric human CstF-77/Drosophila Suppressor of forked proteins rescue suppressor of forked mutant lethality and mRNA 3′ end processing in Drosophila | |
| Shah et al. | Incorporation of an artificial protease and nuclease at the HIV-1 Tat binding site of trans-activation responsive RNA | |
| Gabdarakhmanova et al. | Actinomycin D influence on biosynthesis of extracellular ribonucleases by sporulating bacteria | |
| Cook et al. | 3-Deazapurines |